Benign Prostatic Hyperplasia (BPH): Pathophysiology + Medications Explained

This video breaks down BPH in terms of its symptoms, pathophysiology, mechanism of drugs used to treat it, and high-yield features that distinguish it from prostate cancer. Benign prostatic hyperplasia (BPH) is one of the most common causes of lower urinary tract symptoms in older men. In this video, we break down BPH pathophysiology step by step and explain how BPH medications work, including alpha-1 blockers and 5-alpha reductase inhibitors. #BPH #BenignProstaticHyperplasia #Pathophysiology #Pharmacology #AlphaBlockers #Finasteride #MedicalEducation #USMLE #PAStudent #boardreview We cover: • Static vs dynamic obstruction • Role of DHT in prostate growth • Why BPH causes weak stream, hesitancy, and nocturia • Alpha-1 blockers (tamsulosin, alfuzosin, doxazosin) • 5-alpha reductase inhibitors (finasteride, dutasteride) • Key side effects and board-relevant pearls This video is designed for medical students, PA/NP students, residents, and anyone studying for USMLE, COMLEX, or PANCE.